Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial

Hugh Markus, SC Larsson, W Kuker, UG Schulz, I Ford, PM Rothwell & A Clifton
$\textbf{Objective:}$ To compare in the Vertebral Artery Ischaemia Stenting Trial (VIST) the risks and benefits of vertebral angioplasty and stenting with best medical treatment (BMT) alone for symptomatic vertebral artery stenosis. $\textbf{Methods:}$ VIST was a prospective, randomized, open-blinded endpoint clinical trial performed in 14 hospitals in the United Kingdom. Participants with symptomatic vertebral stenosis ≥50% were randomly assigned (1:1) to vertebral angioplasty/stenting plus BMT or to BMT alone with randomization stratified by site of stenosis...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.